These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24187130)

  • 1. Development of functionally selective, small molecule agonists at kappa opioid receptors.
    Zhou L; Lovell KM; Frankowski KJ; Slauson SR; Phillips AM; Streicher JM; Stahl E; Schmid CL; Hodder P; Madoux F; Cameron MD; Prisinzano TE; Aubé J; Bohn LM
    J Biol Chem; 2013 Dec; 288(51):36703-16. PubMed ID: 24187130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.
    Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM
    ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel functionally selective κ-opioid receptor scaffolds.
    White KL; Scopton AP; Rives ML; Bikbulatov RV; Polepally PR; Brown PJ; Kenakin T; Javitch JA; Zjawiony JK; Roth BL
    Mol Pharmacol; 2014 Jan; 85(1):83-90. PubMed ID: 24113749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.
    White KL; Robinson JE; Zhu H; DiBerto JF; Polepally PR; Zjawiony JK; Nichols DE; Malanga CJ; Roth BL
    J Pharmacol Exp Ther; 2015 Jan; 352(1):98-109. PubMed ID: 25320048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses.
    Dunn AD; Reed B; Erazo J; Ben-Ezra A; Kreek MJ
    ACS Chem Neurosci; 2019 Aug; 10(8):3590-3600. PubMed ID: 31313902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS; Kuhar JR; Song A; Chavkin C
    Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons.
    Schmid CL; Streicher JM; Groer CE; Munro TA; Zhou L; Bohn LM
    J Biol Chem; 2013 Aug; 288(31):22387-98. PubMed ID: 23775075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria.
    Brust TF; Morgenweck J; Kim SA; Rose JH; Locke JL; Schmid CL; Zhou L; Stahl EL; Cameron MD; Scarry SM; Aubé J; Jones SR; Martin TJ; Bohn LM
    Sci Signal; 2016 Nov; 9(456):ra117. PubMed ID: 27899527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology.
    Brust TF
    Handb Exp Pharmacol; 2022; 271():115-135. PubMed ID: 33140224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
    Robinson JD; McDonald PH
    Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse.
    Khan MIH; Sawyer BJ; Akins NS; Le HV
    Eur J Med Chem; 2022 Dec; 243():114785. PubMed ID: 36179400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noribogaine is a G-protein biased κ-opioid receptor agonist.
    Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
    Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
    Bruchas MR; Chavkin C
    Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6'-Guanidinonaltrindole (6'-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment.
    Rives ML; Rossillo M; Liu-Chen LY; Javitch JA
    J Biol Chem; 2012 Aug; 287(32):27050-4. PubMed ID: 22736766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons.
    Ho JH; Stahl EL; Schmid CL; Scarry SM; Aubé J; Bohn LM
    Sci Signal; 2018 Aug; 11(542):. PubMed ID: 30087177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
    Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
    Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosensors Monitor Ligand-Selective Effects at Kappa Opioid Receptors.
    Oberhauser L; Stoeber M
    Handb Exp Pharmacol; 2022; 271():65-82. PubMed ID: 33387066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.
    Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.